Guggenheim lowered the firm’s price target on Danaher (DHR) to $250 from $275 and keeps a Buy rating on the shares. The firm adjusted models ...

Investment analysts at Zacks Research cut their Q1 2025 earnings per share estimates for shares of Danaher in a report issued ...

AI-powered diagnostic tools are revolutionizing the interpretation of medical images with high accuracy, leading to increased adoption. These tools not only improve disease diagnostics but also ...

The general mood among these heavyweight investors is divided, with 43% leaning bullish and 43% bearish. Among these notable ...

Investing.com -- Goldman Sachs upgraded Danaher Corp (NYSE: DHR) to “Buy” from “Neutral,” citing a more attractive valuation ...

Shares of Danaher Corp. DHR shed 1.18% to $210.26 Wednesday, on what proved to be an all-around great trading session for the ...

I’m Dan Brennan, I follow tools and diagnostics. Pleased to be joined with me on stage, CEO of Danaher, Rainer Blair. So Rainer, welcome. Great. Thanks for that. Well, 2024 finished essentially ...

We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against the other ...